Rumah Sakit Umum Pusat Dr. Sardjito adalah rumah sakit umum yang terletak di Kalurahan Sinduadi, Kapanéwon Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta, persis di sebelah barat Fakultas Kedokteran Universitas Gadjah Mada dan di sebelah selatan Fakultas Teknik Universitas Gadjah Mada.

During the past decade, Dr Sardjito Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr Sardjito Hospital" #1 sponsor was "Ina-Respond" with 3 trials, followed by "Fresenius Kabi" with 1 trials sponsored, "Gadjah Mada University" with 1 trials sponsored, "Genova Inc." with 1 trials sponsored and "Kirby Institute" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr Sardjito Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator, "Eurofarma Laboratorios S.A." with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Dr Sardjito Hospital" are "Acute Respiratory Illnesses" (1 trials), "COVID-19" (1 trials), "COVID19" (1 trials), "Caloric Deficit" (1 trials) and "Coronavirus" (1 trials). Many other conditions were trialed in "Dr Sardjito Hospital" in a lesser frequency.

Most popular intervention types in "Dr Sardjito Hospital" are "Other" (3 trials), "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Best Support Treatment" (1 trials), "Chloroquine or Hydroxychloroquine" (1 trials), "Darunavir" (1 trials) and "Dolutegravir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr Sardjito Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Dr Sardjito Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dr Sardjito Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr Sardjito Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".